Patents by Inventor Claire Gilligan

Claire Gilligan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Intravaginal matrix drug delivery devices
    Patent number: 9993424
    Abstract: The present invention relates to a process for the preparation of an intravaginal matrix drug delivery device. The process comprises the steps of combining at least one therapeutic agent in a therapeutically effective amount with at least one biocompatible elastomeric polymer to form a mix; curing said mix in a mold having a shape of said intravaginal drug delivery device, to form a polymer matrix; and maturing said polymer matrix to form the intravaginal drug delivery device. The maturing step alters the release rate characteristics of a device prepared in accordance with the process of the invention.
    Type: Grant
    Filed: March 27, 2003
    Date of Patent: June 12, 2018
    Assignee: Allergan Pharmaceuticals International Limited
    Inventors: Brendan Muldoon, Colin Lorimer, Claire Gilligan
  • Derivative prodrugs of ethinyl estradiol
    Patent number: 7795241
    Abstract: The present invention is a prodrug derivative of ethinyl estradiol according to Formula I:
    Type: Grant
    Filed: July 3, 2006
    Date of Patent: September 14, 2010
    Assignee: Warner Chilcott Company, LLC
    Inventors: James Keown, James William McIlroy, John Alexander King, Claire Gilligan, William Paul Armstrong
  • Novel prodrugs of estradiol
    Publication number: 20070015741
    Abstract: The present invention is a prodrug derivative of estradiol according to Formula I:
    Type: Application
    Filed: July 3, 2006
    Publication date: January 18, 2007
    Inventors: James Keown, James McIlroy, John King, Claire Gilligan, William Armstrong
  • Derivative prodrugs of ethinyl estradiol
    Publication number: 20070015740
    Abstract: The present invention is a prodrug derivative of ethinyl estradiol according to Formula I:
    Type: Application
    Filed: July 3, 2006
    Publication date: January 18, 2007
    Inventors: James Keown, James McIlroy, John King, Claire Gilligan, William Armstrong
  • Estrogen compositions for vaginal administration
    Publication number: 20070004693
    Abstract: Pharmaceutical gel compositions containing estrogen for vaginal administration, as well as a method of making the same, are disclosed.
    Type: Application
    Filed: June 16, 2006
    Publication date: January 4, 2007
    Applicant: WARNER CHILCOTT COMPANY INC.
    Inventors: David Woolfson, Claire Gilligan
  • Topical compositions
    Patent number: 6841161
    Abstract: The invention concerns a topical composition comprising an emulsion of at least one discontinuous phase in a continuous phase, the or each discontinuous phase including a eutectic mixture of first and second pharmaceutically acceptable components which are both pharmacologically active agents and the continuous phase being provided by a pharmaceutically acceptable carrier, the eutectic mixture having a melting point below 40° C. The topical composition may additionally comprise, in the eutectic mixture, a third or fourth pharmaceutically acceptable component.
    Type: Grant
    Filed: May 14, 1998
    Date of Patent: January 11, 2005
    Assignee: Galen (Chemicals) Limited
    Inventors: Clare Passmore, Claire Gilligan
  • Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors
    Patent number: 6416780
    Abstract: This invention relates to an intravaginal shell or core drug delivery device suitable for administration to female humans or animals comprises testosterone or a testosterone precursor in a polymer matrix, surrounded by a sheath, and is capable of releasing the testosterone or testosterone precursor in a substantially zero-order pattern on a daily basis for at least three weeks. The device is intended to restore circulating testosterone levels to the normal physiol, range or to induce supratherapeutic testosterone levels.
    Type: Grant
    Filed: May 1, 2000
    Date of Patent: July 9, 2002
    Assignee: Galen (Chemicals) Limited
    Inventors: Clare Passmore, Claire Gilligan